Provided by Tiger Fintech (Singapore) Pte. Ltd.

Insmed

65.61
-0.1000-0.15%
Post-market: 65.610.00000.00%16:20 EDT
Volume:2.09M
Turnover:137.72M
Market Cap:11.95B
PE:-11.15
High:66.66
Open:65.61
Low:65.07
Close:65.71
Loading ...

Jefferies Initiates Coverage on Insmed With Buy Rating, $105 Price Target

MT Newswires Live
·
13 May

Insmed Initiated at Buy by Jefferies

Dow Jones
·
13 May

Evercore ISI Sticks to Its Buy Rating for Insmed (INSM)

TIPRANKS
·
13 May

Insmed Price Target Maintained With a $90.00/Share by HC Wainwright & Co.

Dow Jones
·
12 May

Insmed Is Maintained at Buy by UBS

Dow Jones
·
10 May

RBC Trims Price Target on Insmed to $99 From $100, Keeps Outperform Rating

MT Newswires Live
·
09 May

Insmed Inc : RBC Cuts Target Price to $99 From $100

THOMSON REUTERS
·
09 May

Insmed’s Promising Pipeline and Strong Financials Justify Buy Rating

TIPRANKS
·
09 May

Insmed’s Strategic Growth and Pipeline Progress Drive Buy Rating

TIPRANKS
·
09 May

Insmed’s Promising Future: Buy Rating Backed by Brensocatib Launch and Strong Clinical Pipeline

TIPRANKS
·
09 May

Insmed Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Stock Track | Insmed Plummets 5.07% as Q1 Earnings Miss Estimates and Wider Losses Disappoint Investors

Stock Track
·
08 May

Insmed Q1 Net Loss Widens, Revenue Increases; 2025 Revenue Guidance Maintained

MT Newswires Live
·
08 May

Earnings Flash (INSM) Insmed Posts Q1 Net Revenue $92.8M, vs. FactSet Est of $91.5M

MT Newswires Live
·
08 May

Earnings Flash (INSM) Insmed Posts Q1 Net Loss $1.42 a Share, vs. FactSet Est of $1.34 Loss

MT Newswires Live
·
08 May

Insmed Q1 EPS $(1.42) Misses $(1.33) Estimate, Sales $92.82M Beat $92.08M Estimate

Benzinga
·
08 May

BRIEF-Insmed Q1 Revenue USD 92.8 Million Vs. IBES Estimate USD 92.1 Million

Reuters
·
08 May

Insmed Outlook FY Revenue USD 405-425 Million

THOMSON REUTERS
·
08 May

Mizuho Securities Keeps Their Buy Rating on Insmed (INSM)

TIPRANKS
·
08 May

Earnings Preview: Insmed (INSM) Q1 Earnings Expected to Decline

Zacks
·
01 May